This content is machine translated Immunotherapy Wider use for CAR-T cell treatment possible in the future? CAR-T cells have solved a central problem in cancer therapy – they make tumors visible again to the immune system. The initial successes in B-cell lymphomas are now attracting a…
View Post 4 min This content is machine translated Hematologic neoplasms Highlights and current data from the world of hematology ASH attendees immersed themselves in the world of hematology at the end of 2019. They learned about current trial data and findings around multiple myeloma, CAR-T cell therapy in LBCL,…
View Post 4 min This content is machine translated Hodgkin's lymphoma Overview of current therapeutic approaches Hodgkin’s disease belongs to the group of malignant lymphomas and is manifested by painless swelling of the lymph nodes, which are very often initially found on the neck or behind…
View Post 2 min This content is machine translated Chronic myeloid leukemia In the long term: first-line therapy with TKI convinces with efficacy Chronic myeloid leukemia is a malignant disease of the bone marrow in which too many white blood cells are produced. In most patients, a genetic alteration of the Philadelphia chromosome…
View Post 2 min This content is machine translated Editorial Swiss Oncology in Motion: Video-based online training courses Educational films in various modules for medical oncologists, hematologists and oncology specialists. Oncology is on the move – research is advancing rapidly and new insights into biology and therapy are…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Basics, Genetics and Guidelines Prof. em. Dr. Richard Herrmann in conversation with PD Dr. med. Jeroen S. Goede, Head of Hematology, Head of the Center for Lymphomas and Leukemias, Kantonsspital Winterthur Video Part 1/3:… CME-Test
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Treatment Overview Prof. em. Dr. Richard Herrmann in conversation with Michael Gregor, M.D., Head of Hematology, Lucerne Cantonal Hospital Video Part 2/3: Treatment Overview CME-Test
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Key Figures for Practice and Outlook for the Future Prof. em. Dr. Richard Herrmann in conversation with Prof. Dr. med. Thorsten Zenz, Senior Physician at the Center for Hematology and Oncology, University Hospital Zurich Video Part 3/3: Key figures… CME-Test
View Post 2 min This content is machine translated Paroxysmal Nocturnal Hemoglobinuria Relief for patients due to longer infusion intervals Chronic destruction of red blood cells is characteristic of paroxysmal nocturnal hemoglobinuria. Mutations in the PIG-A gene lead to a GPI-AP deficit that results in uncontrolled complement activation. C5 complement…
View Post 9 min This content is machine translated Reactive plasmocytoses Polyclonal plasma cell proliferation in focus. Reactive plasmocytoses are rare, but then often pronounced. They must be tested against a reactive (polyclonal) and monoclonal Plasma cell proliferation can be delineated. Accurate differential diagnosis enables effective therapy.
View Post 2 min This content is machine translated Infections in oncology A common complication brought up to date Infections are common complications of systemic therapy in hematologic and oncologic patients. However, there are few uniform definitions and little information on how to effectively treat them.
